Test Price
2,800 AED✅ Home Collection Available
FBN1 Gene Acromicric Dysplasia Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by our DHA-licensed genetic counselor.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The FBN1 Gene Acromicric Dysplasia Genetic Test detects pathogenic variants in the FBN1 gene responsible for acromicric dysplasia, a rare autosomal dominant skeletal dysplasia marked by severe short stature, characteristic facial features, and joint stiffness. This comprehensive next-generation sequencing analysis provides a definitive molecular diagnosis to guide clinical management, genetic counseling, and family planning in the UAE.
| Feature | Our Test (FBN1 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Full gene coverage, identifies single nucleotide variants, small indels, and copy number changes with 99.9% sensitivity | Limited to targeted regions, ~95% sensitivity for point mutations; may miss large deletions/duplications |
| Methodology | Next-Generation Sequencing (NGS) on Illumina® platform with bioinformatic validation | Dideoxy Chain Termination (Sanger) |
| Turnaround Time | 3–4 weeks | 6–8 weeks (per exon) |
Physician Insight & Safety Protocols
Insight from Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA: 9294403): “This FBN1 gene test offers a precise molecular diagnosis for acromicric dysplasia, which is critical for appropriate surveillance and management. However, I emphasize that results must be contextualized with full clinical and family history. Genetic testing is a powerful tool, but it never replaces the comprehensive assessment by your physician.”
Advisory: Medication Continuation
Do not discontinue prescribed medication without consulting your doctor. Genetic test results are not a directive to alter any ongoing treatment plan.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Recent allogeneic blood transfusion (<2 weeks) or bone marrow transplant may introduce donor DNA and lead to false-negative or uninterpretable results. Verify sample source with clinical team before collection.
- ER Red Flags: This is an elective diagnostic test and not a substitute for emergency medical assessment. If the patient experiences severe respiratory distress, acute growth failure, or symptoms of adrenal crisis, seek immediate hospital care.
- Important: Do not use this test for prenatal diagnosis without formal genetic counseling and informed consent. Compliance with UAE regulations for minors requires written parental/guardian authorization.
Patient FAQ & Clinical Guidance
1. What is the FBN1 gene acromicric dysplasia test, and why is it done?
Snippet: This test analyzes the FBN1 gene for mutations causing acromicric dysplasia, a genetic disorder affecting bone growth and connective tissue, to confirm clinical suspicion and guide care.
The FBN1 Gene Acromicric Dysplasia Genetic Test uses next-generation sequencing to scan the entire coding region of the fibrillin-1 gene, identifying pathogenic variants linked to the skeletal dysplasia. It is recommended for children with short stature, characteristic facies, and joint limitations, as well as for family members seeking carrier status or recurrence risk information. Early molecular confirmation allows for tailored multidisciplinary management and accurate genetic counseling.
2. How is the sample collected, and what is the turnaround time?
Snippet: A blood sample, DNA extract, or a blood spot on an FTA card is collected by our DHA-licensed home phlebotomy team; results are reported in 3 to 4 weeks with expedited options available.
We offer VIP home collection (8 AM – 11 PM) following ISO cold-chain protocols. The patient or guardian need only provide a blood draw (venipuncture), one drop on an FTA card, or previously extracted DNA. The sample is transported at controlled temperature to our reference laboratory. The standard turnaround time is 3–4 weeks from sample receipt; urgent requests may be processed within 2–3 weeks upon prior arrangement.
3. Is the test covered by insurance in the UAE?
Snippet: We verify direct billing eligibility with major UAE insurers via WhatsApp at +971 54 548 8731; provide your insurance details for pre‑authorization and our team will assist within 24 hours.
Many UAE insurers cover NGS-based genetic testing for clinical indications like acromicric dysplasia when pre‑authorized by a specialist (pediatrician or clinical geneticist). Our dedicated billing support team checks your policy benefits and facilitates direct billing to reduce out‑of‑pocket cost. Simply send your insurance card and Emirates ID via WhatsApp, and we will guide you through the approval process.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Compliance
Your genetic data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE maintains ISO 9001:2015 certification and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | FBN1 Gene Acromicric Dysplasia Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral blood (whole blood), extracted DNA, or FTA card blood spot |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina® platform |
| ICD-10-CM Code | Q77.8 (Other osteochondrodysplasias) |
| LOINC Code | 51227-9 (FBN1 gene mutation analysis) |
| DHA Facility License & Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians